A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020)

NCT05818137 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

BIOLOGICAL: Sotatercept

Sponsor

Merck Sharp & Dohme LLC